AstraZeneca to buy Alexion for $39B
Bio Pharma Dive
DECEMBER 12, 2020
The deal launches AstraZeneca, a company that has been growing mostly because of newer drugs for cancer and diabetes, into the market for rare disease treatments.
Sat.Dec 12, 2020 - Fri.Dec 18, 2020
362 
Telehealth will be worth about $25 billion in 2021
World of DTC Marketing
DECEMBER 15, 2020
SUMMARY: Deloitte predicts that the percentage of virtual video visits to doctors will rise to 5% globally in 2021, up from an estimated 1% in 2019. While 5% may not sound like much, consider that 8.5 billion doctor’s visits, worth a total of approximately US$500 billion. The most time-consuming task is to make an appointment with your doctor just to ask for a new Rx or an Rx renewal.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Best Features of Mobile Workstations in Pharmaceutical Production
Pharma Mirror
DECEMBER 14, 2020
The future of pharmaceutical manufacturing is mobile. Advances in cloud computing and the onset of Industry 4.0 has led to the proliferation of mobile IT solutions for manufacturing, including pharmaceuticals. Particularly, mobile workstations and tablets are becoming staples of the pharmaceutical manufacturing workflow due to their cost-effectiveness, particularly in demanding environments like cleanrooms, where even modular fixed human-machine interfaces (HMIs) can be exorbitantly priced and c
You Have a Product – Now What? Key Considerations for an Effective Commercial Strategy
Camargo
DECEMBER 15, 2020
Whether a sponsor develops a new product or plans to license an exciting new asset developed somewhere else, commercial success or failure will depend on its understanding of the market and ability to develop an effective commercial strategy. The product may be based on an elegant and compelling scientific premise, but if it does not provide a set of benefits that could change current behaviors, or if it is not accessible to patients, it might be best to consider alternatives.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Moderna's first FDA clearance brings the US a second coronavirus vaccine
Bio Pharma Dive
DECEMBER 18, 2020
The FDA's emergency authorization of the biotech’s shot bolsters an immunization campaign in the U.S. that’s just beginning.
Virtual ad boards
World of DTC Marketing
DECEMBER 16, 2020
Pharma has adapted virtual ad boards which is essential for impact marketing. I’ve noticed, however, that some best practices for ad boards seem to be slipping. Here is a checklist. 1ne: “Let’s have an ad board.” The first question you need to ask is whether you really need an ad board. Ad boards should not be used to tell something you already know. 2wo : What’s our objective?
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Moderna Vaccine Is Highly Protective and Prevents Severe Covid, Data Show
NY Times
DECEMBER 15, 2020
The positive review likely ensures that the F.D.A. will grant emergency authorization for a second coronavirus vaccine this week for millions of Americans.
With trial plans, Novo wagers its diabetes drug can help treat Alzheimer's
Bio Pharma Dive
DECEMBER 16, 2020
Similar diabetes drugs from Novo have shown signs of promise in treating dementia. The Danish biotech is now putting that hypothesis to the test.
Common sense approach to the pharma industry
World of DTC Marketing
DECEMBER 18, 2020
SUMMARY: The “goodwill” that many believe was gained from the development of a Covid-19 may be more of a wish than a reality. Pharma companies are still too focused on profits while people continue to rely on prescription drugs to compensate for unhealthy lifestyles. The headline and byline in a Times editorial said it all “Don’t Fall for Big Pharma’s Savior Act, Heroic work went into the development of the coronavirus vaccines.
Pandemic has made little positive impact on public's view of pharma
Pharma Times
DECEMBER 15, 2020
A new report launched by Takeda has found that just 17% of UK adults surveyed felt their perception of pharma had improved based on the industry's response to COVID-19
Brain Fog Explained as Study Shows SARS-CoV-2 Crosses Blood-Brain Barrier
BioSpace
DECEMBER 17, 2020
A study in Nature Neuroscience shows SARS-CoV-2, the virus responsible for COVID-19, is capable of crossing the blood-brain barrier, likely contributing to symptoms of brain fog and other cognitive effects reported by people infected with the virus.
FDA scientists back safety, efficacy of Moderna's coronavirus vaccine
Bio Pharma Dive
DECEMBER 15, 2020
A review by agency staff affirmed the strongly positive results Moderna reported from a large Phase 3 study, clearing the way for a possible emergency authorization in the coming days.
US starts COVID-19 vaccinations
BioPharma Reporter
DECEMBER 14, 2020
The US has started COVID-19 vaccinations this morning: after the Pfizer/BioNTech vaccine was granted Emergency Use Authorization (EUA) by the FDA on Friday.
Novo Nordisk eyes EU approval for once-weekly semaglutide
Pharma Times
DECEMBER 18, 2020
Danish pharma is seeking approval for drug as a weight management therapy
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Experts Say Benefits of COVID-19 Vaccines Outweigh Risks of Reported Temporary Side Effects
BioSpace
DECEMBER 15, 2020
After four people in the Pfizer-BioNTech's and three people in Moderna’s COVID-19 vaccine trials developed temporary facial weakness or paralysis, some people became concerned that it could happen to them. But experts suggest that the condition, known as Bell’s palsy, is fairly prevalent in the p.
Novartis acquires a small biotech and its trio of brain drugs
Bio Pharma Dive
DECEMBER 17, 2020
More active in neuroscience than most pharmaceutical firms, Novartis would gain three experimental drugs for depression, schizophrenia and movement disorders through the deal.
COVID-19 winter lockdowns & national restrictions drive demand for ‘body and mind’ formulations say SIRIO Europe
Pharma Mirror
DECEMBER 14, 2020
Manufacturers seeking CDMOs that can quickly develop complex formulations offering both body and mind benefits SIRIO Europe (Ayanda) – the European nutraceutical and pharmaceutical contract development and manufacturing organisation (CDMO) and member of SIRIO Group – forecasts a winter surge in requests from nutra brands for new ‘dual benefit’ mood enhancing formulations as a result of COVID-19 measures.
New research reveals impact of childhood type 1 diabetes on mental health
Pharma Times
DECEMBER 16, 2020
Surveys uncovers findings pre- and post-pandemic
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Eureka’s InvisiMask™ Anti-SARS-CoV-2 Nasal Spray Protects for 10 Hours in Preclinical Results
BioSpace
DECEMBER 13, 2020
Eureka Therapeutics' InvisiMask™ Human Antibody Nasal Spray can provide 10 hours of protection from SARS-CoV-2 virus in animal models, according to preclinical results released today. Now it’s heading to clinical trials.
FDA advisers meet to review Moderna's coronavirus vaccine
Bio Pharma Dive
DECEMBER 17, 2020
Support from the advisory committee Thursday would likely result in an emergency authorization for the shot within days. Track the meeting's progress with BioPharma Dive's reporters here.
Machine-learning, robotics and biology to deliver drug discovery of tomorrow
pharmaphorum
DECEMBER 17, 2020
Biology 2.0: Combining machine-learning, robotics and biology to deliver drug discovery of tomorrow. Intelligent OMICS, Arctoris and Medicines Discovery Catapult test in silico pipeline for identifying new molecules for cancer treatment. Medicines discovery innovators, Intelligent OMICS, supported by Arctoris and Medicines Discovery Catapult, are applying artificial intelligence to find new disease ‘drivers’ and candidate drugs for lung cancer.
GSK co-leads investment in ‘disease rebalancing’ Adrestia Therapeutics
Pharma Times
DECEMBER 18, 2020
British pharma company also announces strategic collaboration agreement
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
FDA Approves First Non-Prescription, OTC Test for At-Home COVID-19 Detection
BioSpace
DECEMBER 15, 2020
The U.S. Food and Drug Administration has authorized the first non-prescription, over-the-counter, at-home antigen test that can be used to identify infection with SARS-CoV-2, the virus responsible for COVID-19, in people two years of age or older.
Lilly pays $880M for Prevail, pushing further into genetic medicine
Bio Pharma Dive
DECEMBER 15, 2020
The acquisition marks a significant bet by Lilly on gene therapy's potential to address tough-to-treat neurological disorders like Parkinson's disease.
Have you checked your brand’s temperature?
pharmaphorum
DECEMBER 14, 2020
In today’s fast-paced world how do you make sure your brand messages resonate with your customers and, if they do, how can your brand become even more remarkable? These questions have always been relevant for healthcare communications, but the new world in which we all find ourselves have made them particularly pertinent as our customers’ behaviour and needs changed.
Valneva starts UK-based early-stage COVID-19 vaccine trial
Pharma Times
DECEMBER 17, 2020
French biotech will test vaccine candidate on 150 volunteers across four sites
New Zealand secures COVID-19 vaccines from Novavax and AstraZeneca
BioPharma Reporter
DECEMBER 17, 2020
New Zealand now has enough COVID-19 vaccines for everyone in the country, says the government, as it announces two new supply agreements with Novavax and AstraZeneca today.
Hospitals start coronavirus vaccinations in sweeping, nationwide effort
Bio Pharma Dive
DECEMBER 14, 2020
A New York nurse was among the first to get the shot after FDA authorization late Friday. Many other health systems are either preparing to receive supplies or are already beginning immunizations.
First Coronavirus Vaccines Head to States, Starting Historic Effort
NY Times
DECEMBER 12, 2020
Distributing supplies is a daunting logistical challenge, involving sophisticated tracking equipment, military contingencies and tight security.
EUSA Pharma launches phase III COVID-19 study for siltuximab
Pharma Times
DECEMBER 17, 2020
Study will enrol hospitalised COVID-19 patients with serious viral acute respiratory distress syndrome
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Let's personalize your content